Protein 90K stimulates the immune system in ovarian cancer

被引:0
|
作者
Zeimet, AG
Marth, C
Fuchs, D
Herold, M
Widschwendter, M
Daxenbichler, G
Iacobelli, S
Dapunt, O
机构
[1] UNIV INNSBRUCK, INST MED CHEM & BIOCHEM, A-6020 INNSBRUCK, AUSTRIA
[2] UNIV INNSBRUCK, INNERE MED KLIN, A-6020 INNSBRUCK, AUSTRIA
[3] UNIV G DANNUNZIO, CATTEDRA ONCOL MED, CHIETI, ITALY
来源
关键词
tumor immunology; protein; 90K; interferon; ovarian cancer;
D O I
10.1159/000272613
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Protein 90K is a tumor-associated antigen, which is able to enhance the cytotoxic activity in lymphokine-activated and natural killer cells as well as the IL-2 release in peripheral blood lymphocytes. In our in vitro experiences we observed a stimulatory effect by IFN-alpha and IFN-gamma on 90K-specific mRNA expression and protein release in ovarian cancer cells, and 90K was furthermore found to be a potent stimulator of macrophage activity. Protein 90K seems to be involved in tumor immunology: it may represent a critical link between tumor and immune system.
引用
收藏
页码:44 / 45
页数:2
相关论文
共 50 条
  • [21] TRIPLETT-TRIPLETT ABSORPTION SPECTROSCOPY AT 90K
    BENICKE, D
    ZANKER, V
    BERICHTE DER BUNSEN-GESELLSCHAFT-PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 1974, 78 (11): : 1255 - 1255
  • [22] SEPARATION OF AN ASSOCIATED 90K HEAT-SHOCK PROTEIN FROM THE GLUCOCORTICOID RECEPTOR COMPLEX
    MILLERDIENER, A
    KIRSCH, T
    GROVE, B
    ROBERTSON, N
    LITWACK, G
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1897 - 1897
  • [23] PHOSPHORYLATION OF A PROTEIN OF 90K DALTONS IS A FACTOR IN THE REGULATION OF MELANOMA CELL-GROWTH BY INSULIN
    MCNEELY, T
    SLOMINSKI, A
    BOMIRSKI, A
    PAWELEK, J
    CLINICAL RESEARCH, 1986, 34 (02): : A768 - A768
  • [24] PHOSPHORYLATION OF A PROTEIN OF 90K DALTONS IS A FACTOR IN THE REGULATION OF MELANOMA CELL-GROWTH BY INSULIN
    MCNEELY, T
    SLOMINSKI, A
    BOMIRSKI, A
    PAWELEK, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 86 (04) : 494 - 494
  • [25] 90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis
    Cecamore, Cristina
    Marsili, Manuela
    Salvatore, Roberta
    Troiani, Roberto
    D'Egidio, Maurizia
    Tinari, Nicola
    Pelliccia, Piernicola
    Chiarelli, Francesco
    Marcovecchio, M. Loredana
    Breda, Luciana
    MODERN RHEUMATOLOGY, 2018, 28 (04) : 637 - 641
  • [26] Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression
    Grassadonia, Antonino
    Graziano, Vincenzo
    Pagotto, Sara
    Veronese, Angelo
    Giuliani, Cesidio
    Marchisio, Marco
    Lanuti, Paola
    De Tursi, Michele
    D'Egidio, Maurizia
    De Marino, Pietro
    Brocco, Davide
    Vici, Patrizia
    De Lellis, Laura
    Cama, Alessandro
    Natoli, Clara
    Tinari, Nicola
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [27] Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression
    Antonino Grassadonia
    Vincenzo Graziano
    Sara Pagotto
    Angelo Veronese
    Cesidio Giuliani
    Marco Marchisio
    Paola Lanuti
    Michele De Tursi
    Maurizia D’Egidio
    Pietro Di Marino
    Davide Brocco
    Patrizia Vici
    Laura De Lellis
    Alessandro Cama
    Clara Natoli
    Nicola Tinari
    Cell Death Discovery, 7
  • [28] THE SYNTHESIS, CHARACTERIZATION AND MAGNETISM OF 90K SUPERCONDUCTORS IN THE Y-BA-CU-O SYSTEM
    CAMPBELL, AM
    EDWARDS, PP
    HARRISON, MR
    HIBBS, AD
    JEFFERSON, DA
    JONES, R
    KIRKLAND, AI
    SINN, E
    THANYASIRI, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 194 : 175 - INOR
  • [29] Crystal structure of 4′-O-methylalpinumisoflavone at 90K
    Kingsford-Adaboh, R.
    Ahiano, E.
    Dittrich, B.
    Okamoto, H.
    Kimura, M.
    Ishida, H.
    CRYSTAL RESEARCH AND TECHNOLOGY, 2006, 41 (07) : 728 - 733
  • [30] 90K PROTEIN - A NEW PREDICTOR MARKER OF DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    NATOLI, C
    DIANZANI, F
    MAZZOTTA, F
    BALOCCHINI, E
    PIEROTTI, P
    ANTONELLI, G
    IACOBELLI, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1993, 6 (04) : 370 - 375